Viva Biotech Holdings (HKG:1873)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
1.910
-0.010 (-0.52%)
Apr 17, 2026, 4:08 PM HKT

Viva Biotech Holdings Ratios and Metrics

Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
4,0533,7991,8172,2493,3529,045
Market Cap Growth
6.61%109.02%-19.19%-32.91%-62.94%-48.29%
Enterprise Value
4,3334,0902,3744,2275,80910,494
Last Close Price
1.921.800.861.051.754.71
PE Ratio
19.1715.5310.21--25.63
Forward PE
10.285.155.155.155.1710.88
PS Ratio
2.111.970.860.951.253.50
PB Ratio
0.910.850.450.550.821.88
P/TBV Ratio
2.382.231.331.843.056.01
P/FCF Ratio
--9.3210.4321.69-
P/OCF Ratio
--4.575.327.6894.67
PEG Ratio
-0.810.810.810.810.81
EV/Sales Ratio
2.252.131.121.782.164.06
EV/EBITDA Ratio
9.949.275.169.8111.7823.11
EV/EBIT Ratio
20.6319.029.7119.9219.3236.09
EV/FCF Ratio
--12.1719.6137.58-
Debt / Equity Ratio
0.330.330.340.520.780.68
Debt / EBITDA Ratio
3.363.362.904.716.256.81
Debt / FCF Ratio
--7.019.7220.65-
Net Debt / Equity Ratio
0.060.060.090.240.600.47
Net Debt / EBITDA Ratio
0.610.610.792.224.915.01
Net Debt / FCF Ratio
--1.874.4315.68-3.80
Asset Turnover
0.240.240.270.280.300.26
Inventory Turnover
3.533.534.884.845.617.33
Quick Ratio
1.221.221.261.030.441.44
Current Ratio
1.511.511.671.320.732.14
Return on Equity (ROE)
6.88%6.88%5.92%-2.74%-13.41%7.84%
Return on Assets (ROA)
1.70%1.70%1.98%1.57%2.08%1.83%
Return on Invested Capital (ROIC)
3.85%3.89%3.96%3.74%4.62%4.04%
Return on Capital Employed (ROCE)
3.30%3.30%3.90%3.30%5.10%3.30%
Earnings Yield
6.03%6.44%9.80%-5.69%-17.82%3.90%
FCF Yield
--10.73%9.59%4.61%-6.61%
Payout Ratio
-----5.66%
Buyback Yield / Dilution
18.44%18.44%-41.39%-5.91%2.81%-25.41%
Total Shareholder Return
18.44%18.44%-41.39%-5.91%2.81%-25.41%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.